

Evofem Biosciences, Inc., (NASDAQ: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The Company’s first commercial product, Phexxi™ (lactic acid, citric acid and potassium bitartrate), is the first and only vaginal pH regulator approved in the United States for the prevention of pregnancy. The Company is also advancing EVO100 into Phase 3 clinical trials for the prevention of urogenital transmission of both Chlamydia trachomatis infection (chlamydia) and Neisseria gonorrhoeae infection (gonorrhea) in women.
We will give women everywhere control of their sexual and reproductive health.
2 colaboradores na companhia Evofem Biosciences avaliaram Evofem Biosciences de vários tópicos como nível de exêcutivos e fluidez de trabalho,o mais recente foi mesesatrás.
Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health.









Lack of leadership. Very inexperienced.

Avise Evofem Biosciences que você está Interessado em trabalhar para a companhia, ao mesmo tempo matenha a sua anônimidade. Comparably dará Evofem Biosciences a oportunidade de te contratar quando uma vaga com a sua cara aparecer!
| 50% | Promoters |
|---|---|
| 0% | Passives |
| 50% | Detractors |





Enviar a eles uma mensagem para valiar a cultura da companhia